Modulus Therapeutics

modulustherapeutics.com

Modulus Therapeutics develops machine learning-powered natural killer (NK) cell therapies for use in anti-tumor treatments. It aims to generate NK cell product candidates for cellular therapy companies.

Facts

HQ
Seattle
Sectors
Biotechnology, Cellular therapy, Machine learning, Healthcare
Type
Corporation Seattle business license
Registered name
Modulus Therapeutics Inc Seattle business license
Stage
Seed
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Modulus Therapeutics

See all 6

Augment AI, Led by Napster Co-Founder Jordan Ritter, Launches Private Beta of AI-Powered Productivity Tools After $3.5M Seed Round

Seattle startup Augment AI, spun out of AI2 and led by Napster co-founder Jordan Ritter, has launched a private beta of its AI-powered productivity sidekick designed to take meeting notes and organize research. The company raised $3.5 million in seed funding and offers two apps, Meeting Augment and Memory Augment, to enhance workflow integration with tools like Zoom.

Andreessen Horowitz, Madrona and other tech VCs ramp up bets on AI-driven biotech startups as founders from software enter life sciences

Tech venture capital firms like Andreessen Horowitz and Seattle’s Madrona Venture Group are increasingly investing in life-science startups that use AI, machine learning and data science to speed drug discovery and development. Investors are following founders who transitioned from software to biotech—such as Sujal Patel of Nautilus and Terry Myerson of Truveta—seeing reduced perceived risk and new opportunity at this intersection.

AI2 Spinout BirchAI Raises $3.1M Seed to Automate Healthcare Customer-Support Call Summaries

BirchAI, an AI2 spinout founded in June 2020, raised $3.1 million in seed funding for software that transcribes, summarizes and analyzes healthcare customer-support calls to reduce post-call documentation time and improve employee and patient satisfaction. CEO Kevin Terrell says the Seattle startup targets medical device, pharmaceutical and insurance companies and lets employees edit AI-generated summaries.

Online

Questions about Modulus Therapeutics

What is Modulus Therapeutics?

Modulus Therapeutics is a startup based in Seattle that develops machine learning-powered natural killer (NK) cell therapies for anti-tumor treatments. It aims to generate NK cell product candidates for cellular therapy companies.

What has Modulus Therapeutics been in the news for?

GeekWire reported in February 2022 on growing interest in AI-driven biotech startups as software founders entered life sciences.

Who invested in Modulus Therapeutics, and how much has it raised?

Members of Seattle Flow see Modulus Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Modulus Therapeutics based?

Modulus Therapeutics is based in Seattle.

When was Modulus Therapeutics founded?

Modulus Therapeutics was founded in 2020.